NCT07345767 is a NA clinical trial of Sleep Diary in Short Sleep Duration, sponsored by University of Arizona.

Who is sponsoring NCT07345767?

NCT07345767 is sponsored by University of Arizona.

What drugs are being tested in NCT07345767?

Interventions in NCT07345767: Sleep Diary, Fitbit.

What condition does NCT07345767 study?

NCT07345767 studies Short Sleep Duration.

Is NCT07345767 still recruiting?

NCT07345767 is currently recruiting now. Last updated 13 February 2026.

Last reviewed 2026-02-13 · How we verify

NCT07345767

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hypknowledge Nationwide Sleep Extension

Recruiting now NA Last updated 13 February 2026

What this trial tests

NA trial testing Sleep Diary in Short Sleep Duration in 1,038 participants. Currently enrolling.

Timeline

1 March 2026

Primary endpoint
31 May 2027

31 May 2027

Quick facts

Lead sponsor	University of Arizona
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	other
Enrollment	1,038
Start date	1 March 2026
Primary completion	31 May 2027
Estimated completion	31 May 2027
Sites	1 location across United States

Drugs / interventions tested

Sleep Diary
Fitbit

Conditions studied

Short Sleep Duration — all drugs for Short Sleep Duration →

Sponsor

University of Arizona

Who can join

Adults 18 to 60, any sex, with Short Sleep Duration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main goal of this study is to evaluate whether a manually determined sleep extension intervention is effective at improving sleep and related outcomes among adults who find it difficult to get enough sleep.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Sleep Diary

Trials testing the same drug.

NCT04044495 — Sleep, Rhythms and Risk of Alzheimer's Disease · NA · completed
NCT00507923 — Tibetan Yoga in Improving Fatigue and Sleep in Participants With Stage I-III Breast Cancer · NA · completed

Other University of Arizona trials

Trials by the same sponsor.

NCT04062890 — Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance · Phase 2 · withdrawn
NCT05569486 — Elucidating the Central Mechanisms of Action for Green Light Therapy in Managing Chronic Pain · NA · not yet recruiting
NCT05064111 — Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy · suspended
NCT06567899 — Mechanistic Underpinnings of Preeclampsia · not yet recruiting
NCT07254793 — Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT · Phase 1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07345767 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Arizona
Last refreshed: 13 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07345767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing